Patent 7615611 was granted and assigned to ZymoGenetics on November, 2009 by the United States Patent and Trademark Office.
Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor16.”